HOME Research Insight Abbott Laboratories (US), Roche Diagnostics (Switzerland), and Siemens Healthineers (Germany) Dominated the Global Hepatitis Test Solution/Diagnosis Market



Abbott Laboratories (US), Roche Diagnostics (Switzerland), and Siemens Healthineers (Germany) Dominated the Global Hepatitis Test Solution/Diagnosis Market


The global hepatitis test solution/diagnosis market is estimated to account for USD 2.66 billion in 2018 and is projected to reach USD 3.37 billion by 2023, at a CAGR of 4.9%. Initiatives taken by government and non-government organizations, high burden of hepatitis worldwide, increasing number of blood transfusions & donations, and benefits offered by point of care instruments & kits are the major factors driving this market.

Collaborations, agreements, and partnerships remain at the center of the strategic growth initiatives adopted by most of the key players in the global hepatitis test solution/diagnosis market. Companies such as Abbott Laboratories, Roche Diagnostics, Bio-Rad, DiaSorin, Danaher, and Grifols have been focusing on this inorganic strategy to enhance their market presence. Players also adopted product launches, product approval, and acquisition as growth strategies.

To know the Insights download the pdf brochure

Roche Diagnostics was the largest player in the hepatitis testing market. The company offers a wide range of test kits and systems. The firm mainly focuses on R&D investment and product launches & approvals. In 2017, the company invested ~13% of its total revenue in R&D to develop new product offerings. Geographically, the company operates in different countries across North America, Latin America, Europe, the Middle East, Africa, and Asia. Roche also focuses on collaborations to enhance its market presence.

Abbott Laboratories is an important player in the global hepatitis testing market. The company offers a wide range of products, including assays & reagents, systems, and informatics solutions & services. Abbott focuses on strengthening its position in the market by adopting organic strategies, such as collaborations, agreements, partnerships, and acquisitions. In 2018, the company entered into partnerships with pathology and research centers to expand its geographical presence across the globe.

Some other leading players in the global hepatitis test solution/diagnosis market include Bio-Rad (US), Siemens (Germany), DiaSorin (Italy), QIAGEN (Netherlands), Danaher (US), bioMérieux (France), and Grifols (Spain). These companies have well-established sales and distribution networks across the globe. They also make significant investments in R&D activities to develop innovative technologies and products. Focus on innovation plays an important role in this market.

Related Reports:

Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis B, HCV, HAV, HDV), Technology (ELISA, RDT, PCR, Transcription Mediated Amplification), End User (Hospitals, Diagnostic Laboratories, Blood Banks, Nursing Homes) - Global Forecast to 2023

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports